The FDA Has Given Its Approval To The First HIV Preventive Injection
The Food and Drug Administration (FDA) has authorized the first injectable HIV pre-exposure prophylaxis therapy, giving at-risk persons another choice for preventing sexually transmitted HIV. According to the FDA, Aperture will be available to at-risk adults and adolescents who weigh at least 77 pounds and have previously tested negative for HIV. According to the FDA’s … Read More